AKT1 and cancer: Changes in cellular pathway proteins like PI3K/Akt/mTOR and MAPK/ERK, which are extensively dysregulated in malignant tumors, also support malignant cells’ ability to avoid apoptotic death and contribute to chemotherapy resistance [19].